Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.40 |
| ▸ | ALB | P02768 | 4/20 | 0.40 |
| ▸ | GLP1R | P43220 | 8/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 2/20 | 0.35 |
| ▸ | FNTB | P49356 | 2/20 | 0.35 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10050321 | 1.00 | NOD1 (0.40) | NOD1ALBGLP1RFOLH1FNTA | |
| SCHEMBL4569677 | 0.92 | GLP1R (0.37) | NOD1ALBGLP1R | |
| SCHEMBL9290021 | 0.86 | TLR2 (0.35) | NOD1GLP1R | |
| SCHEMBL4569674 | 0.84 | ALB (0.31) | ALB | |
| SCHEMBL4569676 | 0.75 | ALDH1A1 (0.41) | — | |
| SCHEMBL14063706 | 0.70 | FNTA (0.57) | NOD1ALBGLP1RFOLH1FNTA | |
| SCHEMBL23452088 | 0.68 | NOD1 (0.61) | NOD1ALBGLP1RFOLH1EPHX2 | |
| SCHEMBL13057100 | 0.68 | NOD1 (0.61) | NOD1ALBGLP1RFOLH1EPHX2 | |
| SCHEMBL13057101 | 0.67 | FOLH1 (0.55) | NOD1ALBGLP1RFOLH1FNTA | |
| SCHEMBL32679724 | 0.67 | NOD1 (0.60) | NOD1ALBGLP1RFOLH1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160317673-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS (AL), INC. | 2016-11-03 | — | — | US | disclosed |
| US-9169354-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2015-10-27 | — | — | US | disclosed |
| US-20150273074-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. | 2015-10-01 | — | — | US | disclosed |
| US-20140066577-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-8501899-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120136123-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120123055-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8101706-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160317673-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | NOD1 3134/4885ALB 4565/4885GLP1R 4253/4885 |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | NOD1 3134/4885ALB 4565/4885GLP1R 4253/4885 |
| US-20150273074-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | NOD1 3290/4885ALB 4515/4885GLP1R 4296/4885 |
| US-20140066577-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | NOD1 3134/4885ALB 4565/4885GLP1R 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.